Preoperative systemic therapy (PST) has become an accepted treatment not only for locally advanced but also for early stage breast cancer patients. Clinical trials have demonstrated that the use of PST is equally to adjuvant treatments in terms of overall survival, and has the advantage of increasing rates of breast conservative surgery and rates of pathologic complete response, a surrogate endpoint for the effectiveness of systemic therapy. Initial studies have suggested higher rates of locoregional recurrence with this approach. However, the optimization of systemic and targeted therapy and the multidisciplinary care is key to achieving optimal outcomes in this setting.

Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back? / I.T. Rubio, L. Wyld, F. Cardoso, G. Curigliano, T. Kovacs, P. Poortmans, J. Cortes. - In: THE BREAST. - ISSN 0960-9776. - 41(2018 Oct), pp. 133-135. [10.1016/j.breast.2018.07.008]

Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

G. Curigliano;
2018-10

Abstract

Preoperative systemic therapy (PST) has become an accepted treatment not only for locally advanced but also for early stage breast cancer patients. Clinical trials have demonstrated that the use of PST is equally to adjuvant treatments in terms of overall survival, and has the advantage of increasing rates of breast conservative surgery and rates of pathologic complete response, a surrogate endpoint for the effectiveness of systemic therapy. Initial studies have suggested higher rates of locoregional recurrence with this approach. However, the optimization of systemic and targeted therapy and the multidisciplinary care is key to achieving optimal outcomes in this setting.
Locoregional recurrences; Postoperative systemic therapy; Surgery; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Female; Humans; Mastectomy, Segmental; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Surgery
Settore MED/06 - Oncologia Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
Preoperative Curigliano.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 188.36 kB
Formato Adobe PDF
188.36 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/623241
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact